Farther Finance Advisors, LLC Cidara Therapeutics, Inc. Transaction History

Farther Finance Advisors, LLC

  • $6.63 Trillion
  • Q3 2025

A detailed history of Farther Finance Advisors, LLC transactions in Cidara Therapeutics, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 5 shares of CDTX stock, worth $510. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Holding current value
$510
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025
BUY
$47.87 - $96.98 $239 - $484
5 New
5 $479,000

Others Institutions Holding CDTX

# of Institutions
3
Shares Held
6.16K
Call Options Held
0
Put Options Held
0
View Full List

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $7.15B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email